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EVALUATION: SHOULD THE
ASSESSMENT OF
HEMODYNAMIC
PERFORMANCE DURING
EXERCISE COMPLETE THE
ANALYSIS?
To the Editor:
In a recent publication, Suri and
colleagues1 evaluated the hemody-
namic performance of the latest
generation of biologic aortic valve
prostheses. The results evidenced
small but consistent early postopera-
tive hemodynamic differences among
current third-generation bioprostheses
(Edwards Magna, Sorin Mitroflow,
and St Jude Epic). We read the article
with interest and were also impressed
byDrDavid’s comment in themeeting
discussion. We congratulate Suri and
colleagues1 on this study; however,
we would like to add some comments.
First, Suri and colleagues1 likely
included in their study any type of
aortic valve disease, which could be
misleading for comparative results.
Aortic stenosis, aortic incompetence,
and their combination have differ-
ences in physiology, histology, and
anatomy, leading to different beha-
viors after the valve replacement.
Second, patients were assessed for
hemodynamic performance before
hospital discharge. This is contrary
to previous studies, which indicate
that in vivo values should be taken at
1-year follow-up because gradients
may change during the first postoper-
ative year, with significant impact onThe Journaleither the hemodynamic results or
the exercise capacity.2
Third, any realistic assessment of
hemodynamic behavior of a pros-
thesis should include evaluation
during exercise. Results obtained
under stress are by far more suitable
to evaluate the performance of a
valve type than hemodynamic data
obtained at rest, and they also reflect
more closely the situation in daily
life. In this regard, Gerosa and
colleagues3 used the Sheffield pulse
duplicator to demonstrate in vitro
that different prostheses perform
differently in different hemodynamic
circumstances. In vivo evaluations
are even more difficult. Stress-
induced echocardiographic assess-
ment could be hindered by several
confounding factors: heart rate,
cardiac output, left ventricle diastolic
pattern, hypertension, reduced sys-
temic arterial compliance, and so on.
In a recent study, we evaluated by
echocardiography the hemodynamic
performance at rest and during exer-
cise of 2 different aortic prostheses
of similar size implanted in patients
who underwent surgery for pure aortic
stenosis.4 Although the study
compared a mechanical valve with a
porcine bioprosthesis, our results
validated the technical procedures as
model for evaluations under stress.
As we were aware that the sole
measurement of gradients does
not entirely represent the complex
function of a valve during physical
exercise, we also analyzed the
stress-induced abnormalities of the
cardiac cycle 1 year after aortic valve
replacement. As is widely known, the
total cardiac cycle duration is alge-
braically dependent on the heart rate
(60,000 ms/heart rate), which is the
major determinant affecting diastolic
and systolic duration. Systolic time
has a negative linear correlation with
heart rate. Diastolic time is longer at
low heart rates and decreases more
markedly than systolic time during
exercise. Transprosthetic gradient is
a function of both diastolic durationof Thoracic and Cardiovascular Surgerand systolic/diastolic ratio, which
depends on a number of cofactors
but could also be attributed to the
flexibility of the stent and the geomet-
ric design of the bioprostheses.
These factors interfere with the
delicate physiologic mechanism of
active annulus motion and aortic root
expansion at each phase of the cardiac
cycle, especially during exercise. This
is more valid for mechanical valves
and for 19- to 23-mm bioprostheses.
A meaningful evaluation of a bio-
prosthesis should therefore further
consider the stent flexibility during
exercise and the effective tolerability
of its distortion when upsized.
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TURNDOWN FOR
INTERRUPTED AORTIC ARCH
REPAIR
To the Editor:
Todman and associates1 recently
described favorable outcomes aftery c Volume 146, Number 5 1307
Letters to the Editoruse of the left carotid artery turndown
(LCATD) technique for interrupted
aortic arch. Several techniques to
repair interrupted arch have been
described, including the end-to-
side anastomosis from sternotomy
approach favored by our center.2
The use of the LCATD technique
may no longer be justified by
the avoidance of cardiopulmonary
bypass. We have demonstrated that
the neurodevelopmental outcomes of
these patients is not affected by the
use of cardiopulmonary bypass, pro-
vided circulatory arrest is not used.3
The LCATD technique seems to
have been limited to some patients,
and we would have been interested
to hear the thoughts of Todman and as-
sociates1 on the limitations of this
technique. In particular, we note that
Todman and associates1 included
only 1 patient (2%) with type A inter-
rupted arch and 3 with aberrant right
subclavian artery (6%),1 even though
the prevalences of these anomalies are
usually reported at around 34% and
20%, respectively.2 In addition, we
would have loved to know whether
Todman and associates1 excluded pa-
tients with single ventricle from the
report or whether they found the tech-
nique contraindicated in these in-
stances because of the known
development of subaortic stenosis in
these patients.
Todman and associates1 concluded
that the LCATD technique resulted in
similar outcomes to those described
in the literature. They kindly men-
tioned our work; however, they only
compared their result with the entire
group we reported, whereas we were
actually attempting to demonstrate
the superiority of the end-to-side
repair. Even though our historical se-
ries was not designed as a comparative
study, we believe that the 18-year
survival of 97% (added to an 8% in-
hospital mortality)2 compares favor-
ably with the 67% 15-year survival
achieved after LCATD.1 In addition,
the 18-year freedom from arch reinter-
vention after end-to-side repair was1308 The Journal of Thoracic and78%,2 a figure higher than the 57%
quoted at 15 years after LCATD, espe-
cially if, as it appears, the latter tech-
nique was reserved for a selection of
more favorable patients.1
Finally, we have previously raised
concerns that patients with smaller
arches may be more susceptible to
the development of hypertension if
they do not undergo a more radical
technique of repair.4 We have demon-
strated that the growth of hypoplastic
segment of aortic arches is unreliable,
and we are concerned that some of
their patients may have had hyperten-
sion develop.5 We found the 18-year
freedom from hypertension after in-
terrupted arch repair in our study to
be 88%.2 The finding of a similarly
low incidence of hypertension after
the use of the LCATD technique
would be very interesting.
In conclusion,we believe that unless
further details are given regarding the
potential limitations of the LCATD
technique, it will be difficult to ascer-
tain its usefulness for the treatment of
interrupted aortic arch.
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MITRAL SUBVALVULAR
APPARATUS
To the Editor:
Functional mitral regurgitation is a
group of diseases in which surgical
treatment is quite difficult and out-
comes are not satisfactory when long
term outcomes are considered. In light
of published data on high recurrence
rates with downsizing ring annulo-
plasty, many surgeons and cardiolo-
gists have carried out various studies.
It is obvious that such scientific re-
searches will further expand our hori-
zon on the treatment of functional
mitral regurgitation. In this context,
we appreciate the study by Santana
and colleagues1 suggesting solutions
to this problem. We would like, how-
ever, to discuss some issues probably
missed by these authors.
First, when examined in detail,
some inaccuracies can be seen in the
article’s Figure 1, which illustrates
the placement of a polytetrafluoro-
ethylene graft around papillary
muscles.1 The 3-dimensional configu-
ration of interventricular septum,
papillary muscles, and leaflets is
improperly illustrated. Papillary mus-
cles were represented as if they were
aligned perpendicular to the septum,
with each muscle having chordal in-
sertions to only one leaflet.1 Tradition-
ally, however, it is accepted that in the
left ventricular anterolateral view
papillary muscles are aligned parallel
to the interventricular septum, with
multiple chordal attachments to both
anterior and posterior leaflets.213
